N-terminally modified analogues of glucose-dependent insulinotropic polypeptide exhibit improved insulinotropic activity and antihyperglycaemic potential compared with glucagon-like peptide-1 counterparts

Victor Gault, BD Green, B Greer, P Harriott, Peter Flatt, Finbarr O'Harte

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)545
JournalDiabetologia
Volume45
Issue numberSuppl.
Publication statusPublished - Aug 2002

Cite this